240 related articles for article (PubMed ID: 24527753)
1. Scleromyxedema without paraproteinemia.
Abarzúa AA; Giesen LF; Sandoval MO; González SB
Int J Dermatol; 2014 Aug; 53(8):971-4. PubMed ID: 24527753
[TBL] [Abstract][Full Text] [Related]
2. [Response to thalidomide in scleromyxedema].
Pascualini MF; Caballero Escuti G; Valente E; Kurpis M; Ruiz Lascano A
Medicina (B Aires); 2013; 73(3):252-4. PubMed ID: 23732202
[TBL] [Abstract][Full Text] [Related]
3. Scleromyxedema: successful treatment with thalidomide in two patients.
Amini-Adle M; Thieulent N; Dalle S; Balme B; Thomas L
Dermatology; 2007; 214(1):58-60. PubMed ID: 17191049
[TBL] [Abstract][Full Text] [Related]
4. Intravenous gammaglobulin and thalidomide may be an effective therapeutic combination in refractory scleromyxedema: case report and discussion of the literature.
Efthimiou P; Blanco M
Semin Arthritis Rheum; 2008 Dec; 38(3):188-94. PubMed ID: 18221985
[TBL] [Abstract][Full Text] [Related]
5. Vincristine, idarubicin, dexamethasone and thalidomide in scleromyxoedema.
Laimer M; Namberger K; Massone C; Koller J; Emberger M; Pleyer L; Hintner H; Greil R
Acta Derm Venereol; 2009 Nov; 89(6):631-5. PubMed ID: 19997697
[TBL] [Abstract][Full Text] [Related]
6. Treatment of recalcitrant scleromyxedema with thalidomide in 3 patients.
Sansbury JC; Cocuroccia B; Jorizzo JL; Gubinelli E; Gisondi P; Girolomoni G
J Am Acad Dermatol; 2004 Jul; 51(1):126-31. PubMed ID: 15243538
[TBL] [Abstract][Full Text] [Related]
7. Managing scleromyxedema with intravenous immunoglobulin: acute worsening of scleromyxedema with biclonal gammopathy.
Manousaridis I; Loeser C; Goerdt S; Hassel JC
Acta Dermatovenerol Alp Pannonica Adriat; 2010 Dec; 19(4):15-9. PubMed ID: 21390475
[TBL] [Abstract][Full Text] [Related]
8. An unusual presentation of scleromyxedema as inflammatory myopathy.
Vysakha KV; Poyuran R; Nair SS; Nair M
Acta Myol; 2019 Mar; 38(1):13-16. PubMed ID: 31309176
[TBL] [Abstract][Full Text] [Related]
9. Scleromyxedema, a positive effect with thalidomide.
Jacob SE; Fien S; Kerdel FA
Dermatology; 2006; 213(2):150-2. PubMed ID: 16902294
[TBL] [Abstract][Full Text] [Related]
10. Scleromyxedema: clinical diagnosis and autopsy findings.
Sala AC; Cunha PR; Pinto CA; Alves CA; Paiva IB; Araujo AP
An Bras Dermatol; 2016; 91(5 suppl 1):48-50. PubMed ID: 28300892
[TBL] [Abstract][Full Text] [Related]
11. Scleromyxedema--thalidomide therapy.
Martins A; Paiva Lopes MJ; Tavares Belo R; Rodrigues JC
J Eur Acad Dermatol Venereol; 2008 May; 22(5):622-4. PubMed ID: 18312333
[No Abstract] [Full Text] [Related]
12. Successful treatment of scleromyxedema with oral thalidomide.
Guarenti I; Sebastiani V; Pinto G; de Souza PR; de Almeida H
Int J Dermatol; 2013 May; 52(5):631-2. PubMed ID: 23231733
[No Abstract] [Full Text] [Related]
13. Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema.
Rongioletti F; Rebora A
J Am Acad Dermatol; 2001 Feb; 44(2):273-81. PubMed ID: 11174386
[TBL] [Abstract][Full Text] [Related]
14. [Scleromyxedema].
Sunderkötter C; Bruns T; Pfeiffer C
Dermatologie (Heidelb); 2024 Mar; 75(3):225-231. PubMed ID: 38363313
[TBL] [Abstract][Full Text] [Related]
15. Case for diagnosis. Lichen myxedematosus.
Rebellato PR; Carbonar MB; Tabuti NI; Rastelli GJ
An Bras Dermatol; 2016; 91(6):842-843. PubMed ID: 28099617
[TBL] [Abstract][Full Text] [Related]
16. Scleromyxedema in a 21 year old female patient with acute lymphoblastic leukemia: a case report.
Rabee H; Tayem L; Gharbeyah M; Abugaber D
BMC Dermatol; 2020 Dec; 20(1):18. PubMed ID: 33276772
[TBL] [Abstract][Full Text] [Related]
17. Case report: Scleromyxedema associated with a monoclonal gammapathy: Successful treatment with intravenous immunoglobulins.
Wang SS; Chen QY; Xiang LH
Front Immunol; 2022; 13():1099918. PubMed ID: 36713453
[TBL] [Abstract][Full Text] [Related]
18. Scleromyxedema-like syndrome with systemic involvement in a cat.
Müntener T; Rüfenacht S; Di Palma S; Hartmeier G; Welle M
Vet Pathol; 2010 Mar; 47(2):346-50. PubMed ID: 20110223
[TBL] [Abstract][Full Text] [Related]
19. Letter to the editor.
Abarzúa A; Sandoval M; González S; Giesen L
Int J Dermatol; 2014 Sep; 53(9):1180-1. PubMed ID: 25124465
[No Abstract] [Full Text] [Related]
20. Scleromyxedema with monoclonal gammopathy and neurological involvement: recovery from coma after plasmapheresis?
do Prado AD; Schmoeller D; Bisi MC; Piovesan DM; Dias FS; Staub HL
Int J Dermatol; 2012 Aug; 51(8):1013-5. PubMed ID: 21671910
[No Abstract] [Full Text] [Related]
[Next] [New Search]
